Predictive Value of Cellular Immune Response and Tumor Biomarkers in Patients Surgically Treated for Cervical Cancer in Relation to Clinical Outcomes

Despite complex management of cervical cancer according to the risk stratification for recurrence and local guidelines (radical hysterectomy, meaning the removal of the uterus and cervix, one third of the vagina, the parametrial tissue at the pelvic sidewall and ligature of utero-sacrals with or without lymphadenectomy, followed by adjuvant radio and chemotherapy), up to 40% of patients still develop relapse of their cancer.

[1]  K. Karunaratne.  Prophylactic HPV vaccination – current status , 2012 .

[2]  T. Wu,et al.  Preventive and therapeutic HPV vaccines. , 2007, Current opinion in investigational drugs.

[3]  J. Nyengaard,et al.  Low density of CD3+, CD4+ and CD8+ cells is associated with increased risk of relapse in squamous cell cervical cancer , 2007, British Journal of Cancer.

[4]  F. Mauny,et al.  Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix. , 2006, Gynecologic oncology.

[5]  E. Donadi,et al.  Immune cellular response to HPV: current concepts. , 2004, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[6]  A. Moscicki,et al.  Cell-Mediated Immune Response to Human Papillomavirus Infection , 2001, Clinical Diagnostic Laboratory Immunology.

[7]  A. Moscicki,et al.  Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens. , 2000, The Journal of infectious diseases.

[8]  S. Vermund,et al.  Cytokine profile in genital tract secretions from female adolescents: impact of human immunodeficiency virus, human papillomavirus, and other sexually transmitted pathogens. , 2000, The Journal of infectious diseases.

[9]  S. Vermund,et al.  Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. , 2000, Archives of pediatrics & adolescent medicine.

[10]  A. Fiander,et al.  Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens. , 2000, Cancer research.

[11]  M. Follen,et al.  Synthesis of IFN-γ by CD8+ T cells is preserved in HIV-infected women with HPV-related cervical squamous intraepithelial lesions , 1999 .

[12]  A. Pierangeli,et al.  Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the L1 capsid protein. , 1999, The Journal of general virology.

[13]  B. Sheu,et al.  Reversed CD4/CD8 ratios of tumor‐infiltrating lymphocytes are correlated with the progression of human cervical carcinoma , 1999, Cancer.

[14]  A. Moscicki,et al.  Th1 Cytokine Patterns in Cervical Human Papillomavirus Infection , 1999, Clinical Diagnostic Laboratory Immunology.

[15]  C. Meijer,et al.  Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia. , 1999, The Journal of general virology.

[16]  P. Amerio,et al.  Role of cytokines in epidermal Langerhans cell migration , 1999, Journal of leukocyte biology.

[17]  L. Kalish,et al.  Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. , 1999, Journal of the National Cancer Institute.

[18]  C. Meijer,et al.  Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study. , 1998, Cancer research.

[19]  P. Delvenne,et al.  Correlation of T‐helper secretory differentiation and types of antigen‐presenting cells in squamous intraepithelial lesions of the uterine cervix , 1998, The Journal of pathology.

[20]  I. Arany,et al.  Activation of local cell-mediated immunity in interferon-responsive patients with human papillomavirus-associated lesions. , 1996, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[21]  T. Mosmann,et al.  The expanding universe of T-cell subsets: Th1, Th2 and more. , 1996, Immunology today.

[22]  I. Arany,et al.  Interferon response depends on viral transcription in human papillomavirus-containing lesions. , 1995, Anticancer research.

[23]  H. Hausen,et al.  The effect of the JE (MCP‐1) gene, which encodes monocyte chemoattractant protein‐1, on the growth of hela cells and derived somatic‐cell hybrids in nude mice , 1995, Molecular carcinogenesis.

[24]  E. Partridge,et al.  CD8+ T lymphocytes are recruited to neoplastic cervix , 1995, Journal of Clinical Immunology.

[25]  J. Horiot,et al.  Cervical and vaginal cancer associated with pessary use , 1992, Cancer.

[26]  D. Norris,et al.  Cytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets. , 1990, The Journal of investigative dermatology.

[27]  F. W. Symington,et al.  Recognition of keratinocytes by cytotoxic T cells specific for conventional HLA class-I alloantigen. , 1990, The Journal of investigative dermatology.

[28]  E. Carasevici,et al.  Predictive value of cellular immune response in cervical cancer. , 2009, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[29]  L. Tan,et al.  Gynaecological Oncology: Cervical and vaginal cancer , 2009 .

[30]  H. Kitchener.  Chapter 8 Prophylactic HPV vaccination: current status , 2008 .

[31]  J. Nyengaard,et al.  A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years. , 2008, Gynecologic oncology.

[32]  Ekaterina S Jordanova,et al.  High number of intraepithelial CD8+ tumor-infiltrating lymphocytes is associated with the absence of lymph node metastases in patients with large early-stage cervical cancer. , 2007, Cancer research.

[33]  M. Follen,et al.  Synthesis of IFN-gamma by CD8(+) T cells is preserved in HIV-infected women with HPV-related cervical squamous intraepithelial lesions. , 1999, Gynecologic oncology.

[34]  H. Chao,et al.  Lymphocyte-infiltrated FIGO Stage IIB squamous cell carcinoma of the cervix is a prominent factor for disease-free survival. , 1999, European journal of gynaecological oncology.

[35]  B. Delahunt,et al.  Infiltration By Immunocompetent Cells In Early Stage Invasive Carcinoma Of The Uterine Cervix: A prognostic study , 1996, Pathology.